IPX.AX IperionX (ASX) closes A$4.09 in Mar 2026: 17 Mar earnings may shift price

The market closed with IPX.AX stock at A$4.09, down -33.17% on heavy volume. This sharp move came before an earnings report scheduled for 17 Mar 2026. We see the drop as a clear earnings‑risk reaction. Investors must weigh near‑term volatility against the company’s longer term titanium opportunity. Meyka AI provides real‑time context and data‑driven analysis for this ASX‑listed name.

IPX.AX stock: immediate price reaction

IPX.AX stock fell to A$4.09 from a previous close of A$6.12. The intraday range hit A$3.99 low and A$4.95 high. Volume surged to 4,102,595 versus an average 1,066,426, showing outsized selling pressure ahead of earnings.

Earnings catalyst and timing

Earnings are scheduled for 17 Mar 2026 and may directly drive the next leg of the move. Recent EPS stands at -0.14, and street consensus expects roughly -0.08 for the year. We expect the market to focus on revenue cadence, production updates from Utah, and any guidance on the Stony Creek development.

Financial and valuation snapshot

IperionX (IPX.AX) carries a market cap of A$1,775,754,213 and a negative PE around -37.57. Price to book is 12.73 and the current ratio is 6.99, reflecting a strong cash buffer. Free cash flow remains negative, and EPS is negative, so valuation reflects development‑stage status.

Technicals, liquidity and trading context

Technicals show muted momentum with RSI 44.66 and MACD histogram near 0.01. Average price over 50 days sits at A$6.67 and 200‑day at A$6.13. Relative volume at 2.01 confirms a liquidity spike and increased short‑term volatility.

Analyst views and sector context

Wall Street commentary is mixed, ranging from buy to sell and a reported consensus price target near US$51.00 on ADR listings. The Basic Materials sector average PE is about 18.09, showing IPX.AX trades well outside sector norms. See MarketBeat and Barron’s for recent analyst notes MarketBeat and Barron’s.

Meyka AI rating and forecast

Meyka AI rates IPX.AX with a score out of 100 at 60.02/100, Grade B, suggestion HOLD. This grade factors S&P 500 and sector benchmarks, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects A$8.95 for the next year. Versus the current A$4.09, that implies an upside of 118.85%. Forecasts are model‑based projections and not guarantees. For the company page see the Meyka stock page.

Final Thoughts

Key takeaways for IPX.AX stock centre on earnings risk and long‑run optionality. The market priced a sharp re‑rating today, pushing the price to A$4.09 on volume of 4,102,595. The coming 17 Mar 2026 earnings release will be the immediate catalyst. Operational metrics, pilot plant output in Utah, and any change to project timelines will matter. Valuation remains stretched on book multiples, yet the company keeps a solid current ratio 6.99, limiting immediate solvency risk. Meyka AI’s forecast model projects A$8.95 in 12 months, implying 118.85% upside versus today. That projection is model‑based and not a guarantee. We view IPX.AX stock as speculative ahead of earnings. Use position sizing and monitor the earnings release and related production updates closely.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.